Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Valerie K Arnold MD
483
•Valerie K Arnold MD•December 8, 2004

Valerie K Arnold MD – FDA 483, Dec 8, 2004

Record Details

An FDA inspection was conducted at Valerie Arnold, MD, in Memphis, TN, from November 29 to December 8, 2004. This pre-approval clinical investigator data validation inspection, conducted under compliance program 7348.811, focused on a Phase III study (SLI381-314) of ADDERALL XR sponsored by Shire Pharmaceutical Development Inc. The regulatory framework for the observations cited was 21 CFR 312.62(b), pertaining to the obligation to prepare and maintain adequate and accurate case histories.

The main issues identified in the FDA-483 included several discrepancies between the clinical investigator's source documents and the case report forms. Specifically, changes made in source files regarding Clinical Global Impressions – Improvement (CGI-I) for three patients (03-005, 03-012, 03-014) were not accurately transferred to the case report forms. Additionally, one patient's (03-007) diagnostic interview booklet was found to be incomplete, lacking documentation for all screened disorders. Another observation noted that a blood pressure correction on a case report form (patient 03-002) was initiated but the correct reading was not recorded on the form itself, though it existed in source documentation. The inspection also highlighted inconsistencies in reporting significant weight loss as adverse events. In response to these inspectional observations, the firm's management committed to providing a written response to the FDA.

Company
Valerie K Arnold MD
Inspection date
December 8, 2004
Product type
drugs
Office
New Orleans District Office
People
  • Kristi Frisch (FDA_PERSONNEL)
  • Sean Stanton (FDA_PERSONNEL)
  • Mitchell Fox
  • Sean D. Duke (Vascular Neurologist Investigator)
View Company Profile

ID · d87dc241-60fe-4e4a-a2c6-7d2ef41f15ce

Other documents for Valerie K Arnold MD
  • EIR - 2017-03-15March 15, 2017
  • 483 - 2017-03-15March 15, 2017
  • EIR - 2007-03-09March 9, 2007
  • EIR - 2004-12-08December 8, 2004

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Valerie K Arnold MD
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.